Anti–IL-6 Receptor Antibody Suppresses Visual Dysfunction in AQP4 Peptide-Immunized Mice
IL-6 receptor blockade may be a viable strategy for preventing visual impairment in patients with NMOSD.
Authors
- Shota Miyake
- Yoshichika Katsura (ORCID: https://orcid.org/0000-0002-7213-6770)
- Shinichi Onishi (ORCID: https://orcid.org/0000-0003-1465-6206)
- Yuko Nakatake-Furuie
- Kenichi Serizawa
- Chie Kato
- Makoto Nakamura
Institutions
- Kobe University (JP)
Publication Details
- Journal
- Translational Vision Science & Technology
- Published
- 2026-02-05
- DOI
- https://doi.org/10.1167/tvst.15.2.6
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00